The Presence of Nucleated Red Blood Cells as an Indicator for Increased Mortality and Morbidity in Burn Patients.

Autor:	Jenkins PM; Hurley Medical Center, Trauma Services, Flint, Michigan, USA., Al Daoud F; Hurley Medical Center, Trauma Services, Flint, Michigan, USA., Mercer L; Hurley Medical Center, Trauma Services, Flint, Michigan, USA., Scholten D; Hurley Medical Center, Trauma Services, Flint, Michigan, USA., Wong K; Hurley Medical Center, Trauma Services, Flint, Michigan, USA., Perinjelil V; Hurley Medical Center, Trauma Services, Flint, Michigan, USA., Majeske K; School of Business Administration, Oakland University, Rochester, Michigan, USA., Cranford J; Hurley Medical Center, Trauma Services, Flint, Michigan, USA., Elian G; Michigan State University, College of Human Medicine, East Lansing, Michigan, USA., Nigam T; Michigan State University, College of Human Medicine, East Lansing, Michigan, USA., Carto CA; Michigan State University, College of Human Medicine, East Lansing, Michigan, USA., Sachwani-Daswani GR; Hurley Medical Center, Trauma Services, Flint, Michigan, USA.
Jazyk:	angličtina
Zdroj:	Journal of burn care & research : official publication of the American Burn Association [J Burn Care Res] 2021 Nov 24; Vol. 42 (6), pp. 1210-1214.
DOI:	10.1093/jbcr/irab035
Abstrakt:	Nucleated red blood cells (NRBCs) have been studied in critically ill and injured patients as a predictor of increased in-hospital mortality and poor clinical outcomes. While prior studies have demonstrated the prognostic power of NRBCs in the critical patient, there has been a paucity of literature available describing their value as a prognostic indicator in the severely burned patient. This retrospective observational study was conducted from 2012 to 2017. Inclusion criteria for this study included all burn patients with total body surface area > 10% who were aged ≥ 15 years. Demographic and clinical data were collected from the electronic medical record system. Data analysis consisted of descriptive and comparative analysis using SPSS. Two hundred and nineteen patients (17.5%) met inclusion criteria with 51 (23.3%) patients positive for NRBCs. The presence of NRBCs had an increased mortality rate with an odds ratio of 6.0 (P = .001; 2.5, 14.5); was more likely to appear in older patients (P < .001); and was associated with increased hospital length of stay (P < .001), injury severity scores (P < .001), and complications. The presence of NRBCs even at the low concentrations reported in our study showed a 6-fold increase in the rate of mortality. With the current improvements in burn care leading to higher survival rates, the need to improve upon the numerous models that have been developed to predict mortality in severe burn patients is clear given the significantly increased risk of death that the presence of NRBCs portends. (© The Author(s) 2021. Published by Oxford University Press on behalf of the American Burn Association.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu